Abstract
Gold nanoparticles stabilized with polyethylene glycol were used to study their cytotoxicity and antiviral activity against HIV-1 in the laboratory. The HeLa-CD4-LTR-B-gal cell line was used with gold nanoparticles to determine the cell viability using luminescent assay. The 50% cytotoxicity concentration, IC50 of gold nanoparticles was found to be 1.12 ± 0.05 mg/ml. M-tropic, T-tropic, dual tropic and resistant isolates were inhibited by gold nanoparticles and their inhibition concentration ranged from 0.05 to 0.12 mg/ml. The mechanism of gold nanoparticles against HIV-1 is not clear but it inhibits the HIV-1 fusion. In this study, the gold nanoparticles were used to analyze their mode of antiviral activity and the experimental results showed that they inhibit the viral entry by binding with gp120 and prevent CD4 attachment. These properties of gold nanoparticles make them as an effective antiviral inhibitor.
Keywords: Gold nanoparticle, cytotoxic, broad - spectrum, immune system, viral inhibition, HIV-1, AIDS, antiviral, inhibitor, concentration
Current HIV Research
Title:Gold Nanoparticles as an HIV Entry Inhibitor
Volume: 10 Issue: 8
Author(s): S. Vijayakumar and S. Ganesan
Affiliation:
Keywords: Gold nanoparticle, cytotoxic, broad - spectrum, immune system, viral inhibition, HIV-1, AIDS, antiviral, inhibitor, concentration
Abstract: Gold nanoparticles stabilized with polyethylene glycol were used to study their cytotoxicity and antiviral activity against HIV-1 in the laboratory. The HeLa-CD4-LTR-B-gal cell line was used with gold nanoparticles to determine the cell viability using luminescent assay. The 50% cytotoxicity concentration, IC50 of gold nanoparticles was found to be 1.12 ± 0.05 mg/ml. M-tropic, T-tropic, dual tropic and resistant isolates were inhibited by gold nanoparticles and their inhibition concentration ranged from 0.05 to 0.12 mg/ml. The mechanism of gold nanoparticles against HIV-1 is not clear but it inhibits the HIV-1 fusion. In this study, the gold nanoparticles were used to analyze their mode of antiviral activity and the experimental results showed that they inhibit the viral entry by binding with gp120 and prevent CD4 attachment. These properties of gold nanoparticles make them as an effective antiviral inhibitor.
Export Options
About this article
Cite this article as:
Vijayakumar S. and Ganesan S., Gold Nanoparticles as an HIV Entry Inhibitor, Current HIV Research 2012; 10 (8) . https://dx.doi.org/10.2174/157016212803901383
DOI https://dx.doi.org/10.2174/157016212803901383 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exploring Genetic Diversity in Plants Using High-Throughput Sequencing Techniques
Current Genomics Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Autism: Pathophysiology and Promising Herbal Remedies
Current Pharmaceutical Design Neuroprotective Effects of Drug-Induced Therapeutic Hypothermia in Central Nervous System Diseases
Current Drug Targets Delivering RNA Interference to the Mammalian Brain
Current Gene Therapy Nicotine and Nicotinic Receptor Involvement in Neuropsychiatric Disorders
Current Topics in Medicinal Chemistry Protective Effects of Corticosteroids and Neurosteroids on Cochlear injury
Medicinal Chemistry Proteolytic Degradation of the Amyloid β-Protein: The Forgotten Side of Alzheimers Disease
Current Alzheimer Research Ghetto Poverty and Pollution in Egypt: A Deadly Threat for Western Countries Caused by New and Infectious Mutants. A Cultural, Social and Microbiological Synopsis
Inflammation & Allergy - Drug Targets (Discontinued) Future Targets for Immune Therapy in Colitis?
Endocrine, Metabolic & Immune Disorders - Drug Targets Gene Therapy for Pituitary Tumors
Current Gene Therapy Dietary Regulation of Glucose Metabolism in Metabolic Syndrome
Current Vascular Pharmacology An Historical Perspective on Efforts to Treat Transmissible Spongiform Encephalopathy
CNS & Neurological Disorders - Drug Targets Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases
Current Medicinal Chemistry Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Identification of Genes for a Complex Trait: Examples from Hypertension
Current Pharmaceutical Biotechnology Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update
Current Drug Metabolism A Closer Look at α-Secretase
Current Alzheimer Research Molecular Targeting of Lymphatics for Therapy
Current Pharmaceutical Design Phytotherapeutic and Natural Compound Applications for Age-Related, Inflammatory and Serious Eye Ailments
Current Molecular Pharmacology